← Back to SNTI

Senti Biosciences Holdings, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 14/08/2026Mar 2026Filed 14/08/2026Sep 2025Filed 13/11/2025Jun 2025Filed 14/08/2026Mar 2025Filed 14/08/2026Sep 2024Filed 13/11/2025Jun 2024Filed 13/11/2025Mar 2024Filed 13/11/2025
$0$0$0$0$0$0$0
−$13−$4.2−$18−$15−$14−$29−$11−$12
−$0.41−$0.14−$0.69−$0.56−$1.41−$6.31−$2.45−$2.65
31312626104.64.64.6

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.